In recognition of this last day of September and the close of Blood Cancer Awareness Month, FORUS Therapeutics Inc. is pleased to announce that Health Canada has accepted for review the New Drug Submission (NDS) for once-weekly XPOVIO® (selinexor) in combination with...
FORUS Therapeutics is excited to introduce Kim Newhouse as the Senior Medical Manager. Recognized as a dedicated medical affairs business partner with a drive to deliver with excellence, Kim brings two decades of hematology/oncology launch experience in the Canadian...
We are thrilled to introduce Tracy Nagy as the Senior Medical Science Liaison for Central Canada. Tracy has dedicated her over 35-year career to patients in hematology/oncology including extensive experience as a MSL and as a Nurse Practitioner/Transplant Coordinator...
FORUS Therapeutics is delighted to introduce Deirdre Hay as the Senior Medical Science Liaison for Western Canada. Deirdre has extensive experience in both commercial and medical affairs roles in hematology and oncology, with the last 10 years as a MSL focused on...
We are very pleased to announce that Alison Vanlerberghe has joined the FORUS Therapeutics team as our Market Access Lead. An industry recognized leader in Market Access, Alison brings a wealth of experience and partnership success, having formed multi-stakeholder...
Recent Comments